Topic GILEAD Sciences

Companies GILEAD Sciences

News GILEAD Sciences

• Gilead Sciences to Acquire Pharmasset, Inc. for $11 Billion

  Gilead Sciences, Inc. and Pharmasset, Inc. announced that the companies have signed a definitive agreement under which Gilead will acquire Pharmasset for $137 per share in cash. The transaction, which values Pharmasset at approximately $11 billion, was unanimously approved by Pharmasset’s Board of D more

• Selcia and Gilead Sciences Extend Liver Disease Drug Discovery Collaboration

  Selcia Limited announced a drug discovery collaboration agreement with Gilead Sciences, Inc.. Building on an established partnership following significant progress made to date, Selcia’s chemists and biologists will continue to provide integrated drug discovery services to support Gilead’s liver di more

• Ron Branning Joins Genzyme to Lead Global Product Quality

  Genzyme Corporation announced that Ron Branning, a 30-plus year bio/pharmaceutical veteran specializing in the development of world-class drug and device quality monitoring systems and regulatory compliance management practices, has joined the company as Senior Vice President of Global Product Quali more

Publications GILEAD Sciences

• [News of the Week] Random Sample

  A new species of orchid has been discovered in the primeval tropical forest of the island of New Britain in Papua New Guinea that blooms at night. An Internet psychologist has identified four common characteristics of so-called viral videos. And this week's numbers quantify the amount paid by Gilead more

Market studies GILEAD Sciences

• Belgium Pharmaceuticals and Healthcare Report Q2 2012

  BMI View: Belgium, much like most of the other regional markets, is expected to post negative year-onyear (y-o-y) value growth in its 2012 pharmaceutical sales because of patent expirations and the tightening operating environment. As part of its fiscal austerity programme, the new government is com more

• Israel Pharmaceuticals and Healthcare Report Q2 2012

  BMI View: Following widespread protests in mid-2011, the Israeli government has been under significant pressure to spend more on housing, healthcare and education. While it was not about to tear down the country's privatised healthcare system, it has been able to support it by subsidising sick funds more

• Global Inhaled Antibiotics Market 2011-2015

  TechNavio’s analysts forecast the Global Inhaled Antibiotics market to reach US$875 million by 2015. One of the key factors contributing to this market growth is an increase in the prevalence of infectious diseases. The Global Inhaled Antibiotics market has also been witnessing the trend of huge inv more

Websites GILEAD Sciences